Home | Medical-Newswire.Com:
(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.
In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future
Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.
Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.
AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.
Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.
That places AMIC right in the middle of a potential growth boom.
While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.
In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.
Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.
Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.
It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.
Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.
Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.
Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.
That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.
Still a developing story worth monitoring.
Disclosure: No position.
Follow ADMD developments and other small cap stocks at VFCsStockHouse.com
Contact VFC's Stock House: email@example.com
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Spanish judge orders release of ill boy's parents
2 Sep 2014 at 11:30am
SOTO DEL REAL, Spain (AP) ? Spanish officials have ordered the immediate release of a detained British couple who were wanted by police in the United Kingdom after they took their critically ill child for treatment abroad without doctors' consent.
U.S. pledges 3,000 troops to fight Ebola; experts say more needed
16 Sep 2014 at 10:13am
By James Harding Giahyue and Jeff Mason MONROVIA/WASHINGTON (Reuters) - The United States has pledged to send 3,000 troops West Africa, using its military muscle to battle the biggest ever outbreak of Ebola by building treatment clinics and training health workers to halt the spread of the deadly virus. President Barack Obama is expected to outline the action later on Tuesday, his second announcement of a major military operation in two weeks after his declaration that Washington would bomb Islamic State fighters in the Middle East. The U.S. ...
Tracing the rise of Ebola in West Africa
16 Sep 2014 at 9:51am
JOHANNESBURG (AP) ? Since the Ebola outbreak first emerged in West Africa, The Associated Press has been reporting on it. A timeline compiled from AP dispatches since March shows the dreaded disease being identified in a remote part of Guinea and then spreading to another country and then two more nations with authorities being alternately alarmed or confident.
UN: Nearly $1 billion needed now to stop Ebola
16 Sep 2014 at 9:37am
GENEVA (AP) ? The number of Ebola cases in West Africa could start doubling every three weeks and it could cost nearly $1 billion to contain the crisis, the World Health Organization said Tuesday.
U.S. lawmakers want to curb antibiotic use on farms
16 Sep 2014 at 9:37am
By Brian Grow and P.J. Huffstutter (Reuters) - Two U.S. lawmakers are calling for action to rein in antibiotic use in livestock in response to a Reuters investigation showing how top U.S. poultry firms have been administering drugs to their flocks. U.S. Sen. Kirsten Gillibrand, (D-NY), said she plans to introduce new legislation authorizing the Food and Drug Administration to collect data on ?farm-level antibiotic use.? The pledge was part of a letter Gillibrand sent Tuesday to FDA Commissioner Margaret Hamburg. ...
Prescription Drug Deaths Keep Rising: CDC
16 Sep 2014 at 9:20am
Deaths from prescription drugs quadrupled From 1999 to 2011, the CDC found.
Northwest Bio drug gets first slot under UK early access scheme
16 Sep 2014 at 9:01am
LONDON (Reuters) - An experimental Northwest Biotherapeutics drug for brain tumors is the first medicine to have been selected for fast-track designation under a new early access scheme in Britain. The U.S. firm's cell therapy DCVax-L has been awarded "promising innovative medicine" status, which is the first step in the scheme that allows access to novel drugs months or even years before they are officially licensed for sale, the department of health said on Tuesday. The initiative, which has similarities with a U.S. ...
US to assign 3,000 from US military to fight Ebola
16 Sep 2014 at 8:48am
WASHINGTON (AP) ? The Obama administration is ramping up its response to West Africa's Ebola crisis, preparing to assign 3,000 U.S. military personnel to the afflicted region to supply medical and logistical support to overwhelmed local health care systems and to boost the number of beds needed to isolate and treat victims of the epidemic.
World hunger easing but 1 in 9 people undernourished: food agencies
16 Sep 2014 at 8:25am
By Isla Binnie ROME (Reuters) - The number of hungry people in the world has fallen sharply over the past decade but 805 million, or one in nine of the global population, still do not have enough to eat, three U.N. food and agriculture agencies said on Tuesday. The number of chronically undernourished people dropped by more than 100 million, equivalent to a country the size of the Philippines, according to a report by the United Nations food agency (FAO), International Fund for Agricultural Development (IFAD) and World Food Programme (WFP). ...
Obama to deploy 3,000 troops as Ebola crisis worsens
16 Sep 2014 at 8:15am
By Jeff Mason WASHINGTON (Reuters) - The United States announced on Tuesday it will send 3,000 troops to help tackle the Ebola outbreak as part of a ramped-up plan, including a major deployment in Liberia, the country where the epidemic is spiralling fastest out of control. The U.S. response to the crisis, to be formally unveiled later by President Barack Obama, includes plans to build 17 treatment centers, train thousands of healthcare workers and establish a military control center for coordination, U.S. officials told reporters. ...
Ebola fight will cost $1.0bn, 20,000 cases on horizon: UN
16 Sep 2014 at 8:09am
Geneva (AFP) - Nearly $1.0 billion dollars is needed to fight the Ebola outbreak raging in west Africa, the United Nations said Tuesday, warning that 20,000 could be infected by year end.
4 Warning Signs That You're Burning the Candle at Both Ends
16 Sep 2014 at 8:03am
Have you ever thought you can do it all -- like build Rome in a day? I thought I could. I was like the Energizer Bunny, just going and going and going. At the time I was working in the corporate world at a multinational company. I got caught up in the awe of and not just having one role or two roles, but rather three roles all at the same time....
FDA approves AstraZeneca, Nektar constipation drug
16 Sep 2014 at 7:57am
By Natalie Grover (Reuters) - The U.S. Food and Drug Administration approved an oral therapy to treat opioid-induced constipation developed by Nektar Therapeutics and AstraZeneca Plc. The decision opens the door for peripherally acting mu opioid receptor antagonists, which have been linked with cardiovascular risk in the past. This class of opioid-induced constipation (OIC) drugs are designed to fight the effects of opioid painkillers on the gut without compromising centrally mediated pain relief. ...
Belgium grants jailed rapist, murderer euthanasia
16 Sep 2014 at 10:10am
BRUSSELS (AP) ? A Belgian convicted of murder and rape who has been imprisoned for almost three decades has been granted the right to die after doctors agreed his psychological condition was incurable, an official said Tuesday.
Man Survives Rare Cancer Thanks to New 'Targeted' Therapy
16 Sep 2014 at 7:04am
New treatments use patients' DNA to fight cancer.